7 September 2018, San
Francisco: The global stereotactic
surgery devices market size is expected to reach USD 25.9
billion by 2025, according to a new report by Grand View Research, Inc.,
expanding at a CAGR of 6.1% during the forecast period. Stereotactic surgery is
a minimally invasive alternative for traditional invasive ablation and biopsy
methods. Since, stereotactic surgery has various advantages such as higher
efficacy, minimal or no surgical incisions, and lower risk of damage to healthy
cells, it is replacing conventional radiotherapies. These surgical procedures
have helped overcome drawbacks associated with traditional invasive surgeries,
such as destruction of healthy cells and higher risk of recurrence &
postoperative complications.
Only around 10.0% of the population in low
and middle-income countries have access to radiation therapy, owing to dearth
of radiation therapy devices. A market leader, Elekta, in its 2016 annual
report stated that the number of installations of linear accelerators in
high-income countries was approximately 13,000, whereas the requirement was
around 25,000. Hence, huge demand-supply discrepancy of radiotherapy devices is
likely to open new avenues for major market players in developing countries.
Access Research Report
of Stereotactic Surgery Devices Market @: www.grandviewresearch.com/industry-analysis/stereotactic-surgery-devices-market
Further key findings from the study suggest:
· Linear accelerators (LINAC) accounted for
the leading volume share in 2017, owing to higher affordability and larger
commercial availability
· CyberKnife is poised to exhibit the fastest
growth over the forecast period owing to their growing adoption in developing
countries
· North America dominated the market in 2017
due to number of government initiatives focused on creating awareness regarding
availability of advanced treatment options and presence of developed healthcare
infrastructure
· Some of the major players operating in the
market are Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray
Incorporated
· These players dominate the market with
their strong brand identity and extensive geographical reach attained through
various strategic initiatives such as mergers & acquisitions and
partnership agreements.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global stereotactic
surgery devices market on the basis of device type and region:
Stereotactic Surgery Devices Product
Type Outlook (Revenue, USD Million, 2014 - 2025)
·
Gamma Knife
·
LINAC
·
PBRT
·
CyberKnife
Stereotactic Surgery Devices Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
o
Greece
o
Italy
o
Spain
o
France
o
Belgium
o
Sweden
·
Asia Pacific
o
Japan
o
India
o
China
o
Australia
o
Singapore
o
South Korea
o
Malaysia
o
New Zealand
o
Indonesia
o
Hong Kong
·
Latin America
o
Mexico
o
Brazil
o
Argentina
·
MEA
o
Morocco
o
Kuwait
o
Iran
o
South Africa
Access Press Release of
Stereotactic Surgery Devices Market@: www.grandviewresearch.com/press-release/global-stereotactic-surgery-devices-market
About
Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco.The company provides
syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment